Prestige Consumer Healthcare Recalls Little Remedies Honey Cough Syrup Over Microbial Contamination Concerns

Reuters
18 Jun
Prestige Consumer Healthcare Recalls Little Remedies Honey Cough Syrup Over Microbial Contamination Concerns

Prestige Consumer Healthcare Inc. has announced a nationwide recall of Little Remedies® Honey Cough Syrup due to microbial contamination. The recall affects all lots of the product still within their expiry date, following the detection of Bacillus cereus, a bacterium that can cause food-borne illnesses characterized by symptoms such as nausea, vomiting, stomach cramps, and diarrhea. While healthy individuals may experience only short-term effects, high levels of exposure could be dangerous. Consumers are advised to stop using the product immediately and contact their healthcare provider if any health issues arise. The company is offering refunds for affected products. For further assistance, consumers can contact Medtech via email, phone, or through their website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Consumer Healthcare Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9470468-en) on June 17, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10